CD73-IN-18
CD73-IN-18 (compound 35j) is an orally available inhibitor of extracellular 5-nucleotidase (CD73) . CD73-IN-18 can be used in anti-cancer research[1].
Product Specifications
CAS Number
3037968-61-6
UNSPSC
12352005
Target
CD73
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cd73-in-18.html
Smiles
O=C(C(C1=CC(NCCC2=CC=CC=C2)=C(N=N1)C3=COC=C3)=CN4)NC4=O
Molecular Formula
C20H17N5O3
Molecular Weight
375.38
References & Citations
[1]Xu Y, et al. Discovery of Novel 5- (Pyridazin-3-yl) pyrimidine-2,4 (1H,3H) -dione Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Ecto-5'-nucleotidase. J Med Chem. 2024 Oct 10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6495245-01 0.2 mL
PKC iota, NT (Protein Kinase C iota Type, Atypical Protein Kinase C-lambda/iota, PRKC-lambda/iota, aPKC-lambda/iota, nPKC-iota, PRKCI, DXS1179E) (PE)
Sign In for Pricing
View Details MBS6495245-02 5x 0.2 mL
PKC iota, NT (Protein Kinase C iota Type, Atypical Protein Kinase C-lambda/iota, PRKC-lambda/iota, aPKC-lambda/iota, nPKC-iota, PRKCI, DXS1179E) (PE)
Sign In for Pricing
View Details